SISCAPA Assay Technologies Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Grant
  • Investors
  • 2

SISCAPA Assay Technologies General Information

Description

Developer of tools designed to develop high-sensitivity, specific assays for proteins, including clinical biomarkers. The company delivers tools which combines antibody-based peptide enrichment with quantitative mass spectrometry to provide accurate quantitation of target proteins, enabling researchers in carrying out analysis using a generic workflow, allowing for validation and industrialization of processes for such applications as biomarker validation, protein bioanalysis, pathway research for therapeutic development and monitoring and for use in laboratory-developed tests.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1759 Willard Street Northwest
  • Washington, DC 20009
  • United States
+1 (301) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SISCAPA Assay Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 04-Nov-2014 00.000 Completed Startup
2. Angel (individual) 11-Apr-2014 000 00.000 00.000 Completed Startup
1. Angel (individual) 23-Aug-2012 $562K $562K 00.000 Completed Startup
To view SISCAPA Assay Technologies’s complete valuation and funding history, request access »

SISCAPA Assay Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.00
To view SISCAPA Assay Technologies’s complete cap table history, request access »

SISCAPA Assay Technologies Executive Team (4)

Name Title Board Seat Contact Info
Leigh Anderson Ph.D Co-Founder, Chief Executive Officer and Chairman
Terry Pearson Chief Scientific Officer, Board Member & Co-Founder
Constance Seniff Co-Founder, Vice President of Business Operations & Director
To view SISCAPA Assay Technologies’s complete executive team members history, request access »

SISCAPA Assay Technologies Board Members (3)

Name Representing Role Since
Guo liang Yu SISCAPA Assay Technologies Board Member 000 0000
Gustavo Salem Self Board Member 000 0000
Terry Pearson SISCAPA Assay Technologies Chief Scientific Officer, Board Member & Co-Founder 000 0000
To view SISCAPA Assay Technologies’s complete board members history, request access »

SISCAPA Assay Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SISCAPA Assay Technologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
To view SISCAPA Assay Technologies’s complete investors history, request access »